Oscar Health (NYSE:OSCR) CEO Mark Bertolini Sells 624,244 Shares of Stock

Posted by Francis Steltz on Jul 2nd, 2026

Oscar Health, Inc. (NYSE:OSCR – Get Free Report) CEO Mark Bertolini sold 624,244 shares of the business’s stock in a transaction dated Tuesday, June 30th. The stock was sold at an average price of $28.48, for a total value of $17,778,469.12. Following the transaction, the chief executive officer directly owned 7,751,570 shares of the company’s stock, valued at $220,764,713.60. This represents a 7.45% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Stock Performance

OSCR opened at $31.79 on Thursday. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26. The stock’s 50 day moving average price is $23.86 and its two-hundred day moving average price is $17.66. The firm has a market capitalization of $9.58 billion, a P/E ratio of -53.87, a price-to-earnings-growth ratio of 1.99 and a beta of 2.34. Oscar Health, Inc. has a 12-month low of $10.69 and a 12-month high of $32.06.

Oscar Health (NYSE:OSCR – Get Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.96. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The company had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.90 billion. During the same period in the previous year, the company earned $0.92 earnings per share. The company’s quarterly revenue was up 52.6% compared to the same quarter last year. On average, equities analysts forecast that Oscar Health, Inc. will post 0.47 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts recently commented on OSCR shares. Wells Fargo & Company set a $20.00 target price on shares of Oscar Health and gave the company an “equal weight” rating in a research note on Thursday, June 4th. Wolfe Research started coverage on shares of Oscar Health in a research report on Tuesday, May 5th. They issued a “peer perform” rating on the stock. UBS Group boosted their price objective on shares of Oscar Health from $15.00 to $20.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. Wall Street Zen raised shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, June 14th. Finally, Jefferies Financial Group upgraded shares of Oscar Health from an “underperform” rating to a “hold” rating and increased their target price for the company from $10.00 to $16.00 in a research note on Monday, April 20th. Three investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Oscar Health presently has an average rating of “Hold” and an average target price of $20.78.

Get Our Latest Analysis on OSCR

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Jones Financial Companies Lllp boosted its stake in Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after buying an additional 2,242 shares in the last quarter. Strs Ohio acquired a new position in shares of Oscar Health in the 1st quarter valued at $30,000. Fifth Third Bancorp lifted its holdings in shares of Oscar Health by 148.7% during the 4th quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock worth $34,000 after acquiring an additional 1,413 shares during the period. Quarry LP boosted its position in shares of Oscar Health by 439.8% during the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after acquiring an additional 1,469 shares in the last quarter. Finally, Harel Insurance Investments & Financial Services Ltd. acquired a new stake in shares of Oscar Health during the 1st quarter valued at about $49,000. 75.70% of the stock is owned by institutional investors.

Oscar Health Company Profile

(Get Free Report)

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.